// App-Quantinova.ai

Sa1208 : Sustained Efficacy in Patients With Ulcerative Colitis Treated With Adalimumab: Results From ULTRA 2

Researchers

Presenter

  • Douglas C. Wolf

Principal Investigators

  • William Sandborn

  • Jean-Frederic Colombel

  • Qian Zhou

  • Andreas Lazar

  • Samantha Eichner

  • Anne Robinson

  • Roopal Thakkar

Medical Centers

  • University of California, San Diego, La Jolla, CA

  • Atlanta Gastroenterology Associates, Atlanta, GA

  • University of Calgary, Calgary, AB, Canada

  • Centre Hospitalier Universitaire Marseille, Marseille, France

Locations

  • United States

  • Canada

  • France

Companies

  • AbbVie Inc.

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • open label

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved